Xencor (NASDAQ: XNCR) insider transactions
In the twelve months to 10 November 2026, executives and directors of Xencor reported 18 open-market sales of 268,162 shares ($3.9m) and 0 open-market purchases, by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 18 June 2026 | Feigal Ellen | Director | Open-market sale, 10b5-1 plan | −6,843 | $13.06 | 12,340 | Form 4 |
| 16 June 2026 | Gorman Kevin Charles | Director | Grant or award | +10,302 | — | 21,680 | Form 4 |
| 16 June 2026 | Simpson Todd E | Director | Grant or award | +10,302 | — | 23,988 | Form 4 |
| 16 June 2026 | Ranieri Richard J | Director | Grant or award | +10,302 | — | 24,011 | Form 4 |
| 16 June 2026 | Montgomery Alan Bruce | Director | Grant or award | +10,302 | — | 25,849 | Form 4 |
| 16 June 2026 | Gustafson Kurt A | Director | Grant or award | +10,302 | — | 25,011 | Form 4 |
| 16 June 2026 | Klencke Barbara | Director | Grant or award | +10,302 | — | 29,974 | Form 4 |
| 16 June 2026 | Feigal Ellen | Director | Grant or award | +10,302 | — | 22,642 | Form 4 |
| 16 June 2026 | Deshaies Raymond Joseph | Director | Grant or award | +10,302 | — | 10,302 | Form 4 |
| 15 June 2026 | Gorman Kevin Charles | Director | Open-market sale, 10b5-1 plan | −7,527 | $12.31 | 11,378 | Form 4 |
| 15 June 2026 | Ranieri Richard J | Director | Open-market sale, 10b5-1 plan | −5,474 | $12.31 | 13,709 | Form 4 |
| 15 June 2026 | Montgomery Alan Bruce | Director | Open-market sale, 10b5-1 plan | −5,064 | $12.31 | 15,547 | Form 4 |
| 15 June 2026 | Gustafson Kurt A | Director | Open-market sale, 10b5-1 plan | −5,474 | $12.31 | 14,709 | Form 4 |
| 10 April 2026 | Cornelissen Bart Jan | Sr. Vice President & CFO | Open-market sale | −3,499 | $12.29 | 75,898 | Form 4 |
| 6 March 2026 | Dahiyat Bassil I | President & CEO | Open-market sale | −6,606 | $11.02 | 546,316 | Form 4 |
| 6 March 2026 | Desjarlais John R | Sr. Vice President & Cso | Open-market sale | −2,502 | $11.02 | 263,831 | Form 4 |
| 6 March 2026 | Eckert Celia | SVP, General Counsel | Open-market sale | −1,767 | $11.02 | 76,918 | Form 4 |
| 5 March 2026 | Dahiyat Bassil I | President & CEO | Open-market sale | −14,870 | $11.25 | 552,922 | Form 4 |
| 5 March 2026 | Desjarlais John R | Sr. Vice President & Cso | Open-market sale | −4,118 | $11.25 | 266,333 | Form 4 |
| 5 March 2026 | Eckert Celia | SVP, General Counsel | Open-market sale | −3,244 | $11.25 | 78,685 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Xencor page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.